Diaceutics PLC (AIM:DXRX)
London · Delayed Price · Currency is GBP · Price in GBX 132.77
-0.73 (-0.55%)
Aug 1, 2025, 1:15 PM GMT+1
Verve Therapeutics Market Cap
Diaceutics has a market cap or net worth of 112.86 million as of August 1, 2025. Its market cap has increased by 0.51% in one year.
Market Cap
112.86M
Enterprise Value
101.18M
Revenue
32.16M
Ranking
n/a
PE Ratio
n/a
Stock Price
$132.77
Market Cap Chart
Since March 21, 2019, Diaceutics's market cap has increased from 66.45M to 112.86M, an increase of 69.84%. That is a compound annual growth rate of 8.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 112.86M | 6.41% |
| Dec 31, 2024 | 106.07M | 44.67% |
| Dec 29, 2023 | 73.32M | 15.14% |
| Dec 30, 2022 | 63.68M | -25.74% |
| Dec 31, 2021 | 85.75M | -23.60% |
| Dec 31, 2020 | 112.23M | 58.13% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 21, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 173.02B |
| GSK plc | 56.40B |
| Haleon | 32.99B |
| Smith & Nephew | 10.33B |
| ConvaTec Group | 5.00B |
| Hikma Pharmaceuticals | 4.36B |
| HUTCHMED (China) | 2.45B |
| Oxford Nanopore Technologies | 1.97B |